Basic Information
Basic information for MIR9-3HG-253-47aa
Peptide Name MIR9-3HG-253-47aa
Genome Position chr15:89396678-89396818[+]
Species Human
Peptide Sequence MYWKSTSGEWGWGSALFYTVIFSFHAPKVLLLEDVKRFNVIGLTSVN
Peptide Length 47
Unique No (MIR9-3HG-201-47aa,MIR9-3HG-212-47aa,MIR9-3HG-213-47aa,MIR9-3HG-214-47aa,MIR9-3HG-218-47aa,MIR9-3HG-219-47aa,MIR9-3HG-220-47aa,MIR9-3HG-221-47aa,MIR9-3HG-222-47aa,MIR9-3HG-226-47aa,MIR9-3HG-227-47aa,MIR9-3HG-233-47aa,MIR9-3HG-241-47aa,MIR9-3HG-246-47aa,MIR9-3HG-247-47aa,MIR9-3HG-251-47aa,MIR9-3HG-252-47aa)
Grand Average of Hydropathicity 0.3021
Relative Molecular Mass 6225
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000671447;MIR9-3HG-253
Transcript Length 4989
Coding Ability 0.47
DNA Sequence Corresponding to Peptide ATGTACTGGAAGTCTACCTCTGGGGAGTGGGGATGGGGGAGTGCACTCTTCTATACTGTTATATTTTCTTTTCATGCTCCTAAGGTACTTTTATTGGAAGATGTAAAGCGGTTCAATGTAATAGGCTTAACTTCTGTCAAC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :